Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Morandi

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Oncotarget|April 13, 2016
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesisMarta Anna Kowalik, Giulia Guzzo, Andrea Morandi, et al.
Molecular Oncology|June 26, 2025
Targeting carbonic anhydrase IX/XII prevents the anti-ferroptotic effect of stromal lactic acid in prostate carcinomaElisa Pardella, Giuseppina Comito, Luigi Ippolito, et al.
Cell Reports|July 4, 2019
Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast CancerMarina Bacci, Nicla Lorito, Luigi Ippolito, et al.
Nanoscale|February 10, 2022
A novel phage display based platform for exosome diversity characterizationDomenico Maisano, Selena Mimmi, Vincenzo Dattilo, et al.
Cancer Research|February 9, 2022
Lactate Rewires Lipid Metabolism and Sustains a Metabolic-Epigenetic Axis in Prostate CancerLuigi Ippolito, Giuseppina Comito, Matteo Parri, et al.
Journal of Hepatology|January 19, 2020
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogrammingMarta Anna Kowalik, Elisabetta Puliga, Lavinia Cabras, et al.
The Lancet. Oncology|February 1, 2024
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendationsIcro Meattini, Carlotta Becherini, Saverio Caini, et al.
Cancer Research|November 7, 2025
ESR1 Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast CancerFrancesca Bonechi, Marina Bacci, Nicla Lorito, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2023
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: A systematic review and meta-analysisViola Salvestrini, Kyubo Kim, Saverio Caini, et al.
Gut|May 27, 2022
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancerMaria Chiara De Santis, Luca Gozzelino, Jean Piero Margaria, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Oncotarget|April 13, 2016
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesisMarta Anna Kowalik, Giulia Guzzo, Andrea Morandi, et al.
Molecular Oncology|June 26, 2025
Targeting carbonic anhydrase IX/XII prevents the anti-ferroptotic effect of stromal lactic acid in prostate carcinomaElisa Pardella, Giuseppina Comito, Luigi Ippolito, et al.
Cell Reports|July 4, 2019
Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast CancerMarina Bacci, Nicla Lorito, Luigi Ippolito, et al.
Nanoscale|February 10, 2022
A novel phage display based platform for exosome diversity characterizationDomenico Maisano, Selena Mimmi, Vincenzo Dattilo, et al.
Cancer Research|February 9, 2022
Lactate Rewires Lipid Metabolism and Sustains a Metabolic-Epigenetic Axis in Prostate CancerLuigi Ippolito, Giuseppina Comito, Matteo Parri, et al.
Journal of Hepatology|January 19, 2020
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogrammingMarta Anna Kowalik, Elisabetta Puliga, Lavinia Cabras, et al.
The Lancet. Oncology|February 1, 2024
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendationsIcro Meattini, Carlotta Becherini, Saverio Caini, et al.
Cancer Research|November 7, 2025
ESR1 Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast CancerFrancesca Bonechi, Marina Bacci, Nicla Lorito, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2023
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: A systematic review and meta-analysisViola Salvestrini, Kyubo Kim, Saverio Caini, et al.
Gut|May 27, 2022
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancerMaria Chiara De Santis, Luca Gozzelino, Jean Piero Margaria, et al.
Pageof 7